Ohlhausen backs FTC view that no-‘authorized generics’ deals can be anticompetitive
Republican US Federal Trade Commissioner Maureen Ohlhausen said Tuesday she backed the agency view that a branded drugmaker’s agreement to not offer an 'authorized generic' product to compete with a rival...To view the full article, register now.
Already a subscriber? Click here to view full article